Atrial fibrillation (AF or AFib) is a common type of arrhythmia, or irregular heartbeat. The Librexia AF Study, evaluating an investigational medication to reduce the risk of AF complications, is enrolling adults with AF. If you are 18 years of age or older and have been diagnosed with AF, you may be able to join the Librexia AF Study.

Medical Condition: Atrial Fibrillation

Age: 18 years and older

Commitment Duration: up to 4 years

Number of Visits in study: up to 16

Patient compensation will be available.

Must be an established Jackson Clinic patient. Click Apply for this Study Now to give us some information about you. Someone from our Clinical Research team will reach out to you with more information.